Literature DB >> 8611335

The hepatorenal syndrome.

G Van Roey1, K Moore.   

Abstract

Hepatorenal syndrome may occur in any form of severe liver disease. It appears less common in children than adults, but still carries a poor prognosis. There are several factors involved in its aetiology, including a decreased renal perfusion pressure, activation of the renal sympathetic nervous system and increased synthesis of several vasoactive mediators, which may modulate glomerular filtration by acting as both renal vasoconstrictors and dynamic regulators of the glomerular capillary ultrafiltration coefficient, through their action on mesangial cells. This review will discuss the pathophysiology of the hepatorenal syndrome and some of the principles of management of patients with renal failure and severe liver disease. The role of renal support and liver transplantation will also be covered.

Entities:  

Mesh:

Year:  1996        PMID: 8611335     DOI: 10.1007/bf00863460

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  100 in total

Review 1.  Renal autoregulation: perspectives from whole kidney and single nephron studies.

Authors:  L G Navar
Journal:  Am J Physiol       Date:  1978-05

2.  Raised renal venous pressure: direct cause of renal sodium retention in cirrhosis?

Authors:  J H Henriksen; H Ring-Larsen
Journal:  Lancet       Date:  1988-07-09       Impact factor: 79.321

3.  Increased production of cysteinyl leukotrienes in hepatorenal syndrome.

Authors:  K P Moore; G W Taylor; N H Maltby; D Siegers; R W Fuller; C T Dollery; R Williams
Journal:  J Hepatol       Date:  1990-09       Impact factor: 25.083

4.  The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.

Authors:  A Ochs; M Rössle; K Haag; K H Hauenstein; P Deibert; V Siegerstetter; M Huonker; M Langer; H E Blum
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

5.  No reinnervation of hepatic sympathetic nerves after liver transplantation in human subjects.

Authors:  M Kjaer; J Jurlander; S Keiding; H Galbo; P Kirkegaard; E Hage
Journal:  J Hepatol       Date:  1994-01       Impact factor: 25.083

6.  Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease.

Authors:  R D Zipser; J C Hoefs; P F Speckart; P K Zia; R Horton
Journal:  J Clin Endocrinol Metab       Date:  1979-06       Impact factor: 5.958

7.  Renal failure in children with hepatic failure undergoing liver transplantation.

Authors:  D Ellis; E D Avner; T E Starzl
Journal:  J Pediatr       Date:  1986-03       Impact factor: 4.406

8.  Hepatorenal syndrome without avid sodium retention.

Authors:  F J Dudley; G C Kanel; L J Wood; T B Reynolds
Journal:  Hepatology       Date:  1986 Mar-Apr       Impact factor: 17.425

9.  Kidney, lower limb and whole-body uptake and release of catecholamines in alcoholic liver disease.

Authors:  J H Henriksen; H Ring-Larsen; N J Christensen
Journal:  Clin Physiol       Date:  1988-06

10.  Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis.

Authors:  D G Bichet; V J Van Putten; R W Schrier
Journal:  N Engl J Med       Date:  1982-12-16       Impact factor: 91.245

View more
  6 in total

Review 1.  Liver transplantation in the UK.

Authors:  S R Bramhall; E Minford; B Gunson; J A Buckels
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

2.  Dialysis-dependent acute kidney injury in children with end-stage liver disease: response to Deep et al.

Authors:  Martin Kreuzer; Lars Pape
Journal:  Pediatr Nephrol       Date:  2016-02-22       Impact factor: 3.714

Review 3.  Renal function following hematological stem cell transplantation in childhood.

Authors:  Ludwig Patzer; Karim Kentouche; Felix Ringelmann; Joachim Misselwitz
Journal:  Pediatr Nephrol       Date:  2003-04-29       Impact factor: 3.714

4.  Dialysis-dependent acute kidney injury in children with end-stage liver disease: prevalence, dialysis modalities and outcome.

Authors:  Martin Kreuzer; Dagmar Gähler; Annette C Rakenius; Jenny Prüfe; Thomas Jack; Eva-Doreen Pfister; Lars Pape
Journal:  Pediatr Nephrol       Date:  2015-08-01       Impact factor: 3.714

Review 5.  New management options for end-stage chronic liver disease and acute liver failure: potential for pediatric patients.

Authors:  Dominique Debray; Nadya Yousef; Philippe Durand
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 6.  Hepatorenal syndrome in children: a review.

Authors:  Sarah Tayná de Carvalho; Pollyanna Faria Fradico; Maria Luiza Barreto Cazumbá; Ramon Gustavo Bernardino Campos; Priscila Menezes Ferri Liu; Ana Cristina Simões E Silva
Journal:  Pediatr Nephrol       Date:  2020-10-01       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.